HAMP and metabolic dysfunction-associated steatotic liver disease: Valenti et al. [59] reported the effect of the manipulation of intracellular iron on the release of atherogenic cytokines in human differentiating monocytes of patients with NAFLD, with Metabolic Syndrome, and with mild iron overload by treatment cells with iron salts or with hepcidin.